Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
83 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-317 |
Cash Flow (TTM) (Millions $) |
27 |
Capital Exp. (TTM) (Millions $) |
4 |
Alder Biopharmaceuticals Inc
Alder Biopharmaceuticals Inc. is a biotechnology company that specializes in the discovery and development of therapeutic antibodies for the treatment of migraine. The company's primary product, called eptinezumab, is an antibody designed to block a particular protein that is believed to play a role in the onset of migraines. Alder Biopharmaceuticals aims to provide innovative and effective treatments for migraine sufferers, addressing a significant unmet medical need. The company is based in the United States and is committed to improving the quality of life for patients with migraine.
Company Address: 11804 North Creek Parkway South Bothell 98011 WA
Company Phone Number: 205-2900 Stock Exchange / Ticker: ALDR
|